section name header

Evidence summaries

Intra-Articular Lidocaine Vs. Intravenous Analgesia for Manual Reduction of Shoulder Dislocation

Intra-articular lidocaine may be equal to intravenous analgesia (with or without sedation) for reduction of acute anterior shoulder dislocation in terms of immediate success rate, pain during or after reduction and reduction failure. Level of evidence: "C"

A Cochrane review [Abstract] 1 included 5 studies with a total of 211 subjects. There was no difference in the immediate success rate of intra-articular lidocaine (lignocaine; IAL) when compared with intravenous analgesia with or without sedation (IVAS) in the closed manual reduction of acute anterior shoulder dislocation (RR 0.95; 95% CI 0.83 to 1.10). There were significantly fewer adverse effects associated with IAL compared with IVAS (RR 0.16; 95% CI 0.06 to 0.43). The mean time spent in the emergency department was significantly less with IAL compared with IVAS (MD 109.46 minutes; 95% CI 84.60 to 134.32). One trial reported significantly less time for reduction with IVAS (105 seconds; 95% CI 84.0 to 126.1) compared with IAL (284.6 seconds; 95% CI 185.3 to 383.9). One trial reported no joint infection associated with intra-articular lignocaine injection and no mortality associated with either IAL or IVAS.

Comment: The quality of evidence is downgraded by limitations in study quality (inadequate or unclear allocation concealment) and byimprecise results (limited study size for each comparison).

References

  • Wakai A, O'Sullivan R, McCabe A. Intra-articular lignocaine versus intravenous analgesia with or without sedation for manual reduction of acute anterior shoulder dislocation in adults. Cochrane Database Syst Rev 2011;4:CD004919 [PubMed]

Primary/Secondary Keywords